Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of mesenchymal stem cells
(MSCs) obtained from bone marrow for the treatment of adults with active proliferative lupus
nephritis. The objective of this study is to evaluate the efficacy of mesenchymal stem cells
(MSCs) in achieving a full response in the treatment of Lupus Nephritis (LN) during its
induction period.
Phase:
Phase 2
Details
Lead Sponsor:
Red de Terapia Celular
Collaborators:
Hospital Clínico Universitario de Valladolid Hospital del Río Hortega University of Valladolid